Results for IRAKLIA show noninferiority for Sanofi's on-body delivery system for isatuximab, compared with IV administration.

New data from two clinical studies demonstrated that Sarclisa administered subcutaneously via an investigational on-body injector shortened treatment time to minutes with similar efficacy and safety ...

ASCO: new Sarclisa data support subcutaneous administration with on-body injector . New data from two clinical studies demonstrated that Sarclisa administered subcutaneously via a ...

Wegovy (semaglutide) is approved by the U.S. Food and Drug Administration (FDA) for weight loss and weight management in ...

Though they are both multiple myeloma drugs with the same mechanism of action, Sanofi’s Sarclisa has had difficulty competing ...

The ranibizumab ocular implant (Susvimo) reduces the need for frequent intravitreal anti-VEGF injections in patients with neovascular age-related macular degeneration or diabetic macular edema, and ...

J Midwifery Womens Health. 2008;53(2):115-122. The mechanisms of action for sterile water injections are not fully clear, but the Gate Control Theory is one logical explanation. This theory was ...

There is a virtual component and an in-person assessment where candidates must successfully administer an intramuscular and a subcutaneous injection to receive a certificate of completion for the ...

We consider the implications of different staffing models for the work and education of clinicians in nursing ... following an analysis of twenty-two site visits and the results of twenty focus ...

Yes—when combined with diet, exercise, and clinical monitoring, Ozempic has helped many patients in Dubai and around the ...